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 High tumour entropy predicts deep myometrial invasion and cervical stroma invasion. 
 High tumour kurtosis predicts reduced recurrence- and progression-free survival. 





To enable more individualised treatment of endometrial cancer, improved methods for 
preoperative tumour characterization are warranted. Texture analysis is a method for 
quantification of heterogeneity in images, increasingly reported as a promising diagnostic tool 
in oncological imaging, but largely unexplored in endometrial cancer 
 
AIM 
To explore whether tumour texture features from preoperative computed tomography (CT) are 
related to known prognostic histopathological features and to outcome in endometrial cancer 
patients. 
 
MATERIALS AND METHODS 
Preoperative pelvic contrast-enhanced CT was performed in 155 patients with histologically 
confirmed endometrial cancer. Tumour ROIs were manually drawn on the section displaying 
the largest cross-sectional tumour area, using dedicated texture analysis software. Using the 
filtration-histogram technique, the following texture features were calculated: mean, standard 
deviation, entropy, mean of positive pixels (MPP), skewness, and kurtosis. These imaging 
markers were evaluated as predictors of histopathological high-risk features and recurrence- 
and progression-free survival using multivariable logistic regression and Cox regression 
analysis, including models adjusting for high-risk status based on preoperative biopsy, 
magnetic resonance imaging (MRI) findings, and age. 
 
RESULTS 
High tumour entropy independently predicted deep myometrial invasion (odds ratio [OR] 
3.7, p=0.008) and cervical stroma invasion (OR 3.9, p=0.02). High value of MPP (MPP5 
>24.2) independently predicted high-risk histological subtype (OR 3.7, p=0.01). Furthermore, 
high tumour kurtosis tended to independently predict reduced recurrence- and progression-
free survival (HR 1.1, p=0.06). 
 
CONCLUSION 
CT texture analysis yields promising imaging markers in endometrial cancer and may 
supplement other imaging techniques in providing a more refined preoperative risk 





Intratumour heterogeneity at the genetic or histological level is reportedly a driver of 
carcinogenesis, neoplastic progression and therapeutic resistance (1-4). In the diagnostic 
workup of most cancer types, imaging is an important cornerstone, providing non-invasive, 
high resolution, whole-tumour visualisation. In recent years, assessment of tumour image 
heterogeneity has provided important insights into tumour phenotype, and several risk 
stratification tools based on radiomics have been proposed (5). 
Endometrial cancer is the most common gynaecological malignancy in developed 
countries, and the incidence is reported to be increasing (6). The current staging system, revised 
by the International Federation of Gynecology and Obstetrics (FIGO) in 2009 (7) is surgical, 
which implies that prognostication is largely based on results from primary surgical staging, 
thus after the surgical treatment. Hysterectomy with bilateral salpingo-oophorectomy comprises 
the standard primary surgical treatment. Pelvic and/or para-aortic lymphadenectomy is 
additionally performed in selected patients according to guidelines varying between 
institutions. The depth of myometrial and cervical tumour invasion, as well as the histological 
type and grade, are established markers associated with presence of lymph node metastases, 
post-treatment recurrence and patient survival (8). If these parameters could be accurately 
predicted preoperatively, a shift towards preoperative decision-making would be facilitated. In 
general, to enable more individualised surgical treatment and to avoid surgical overtreatment, 
improved methods for preoperative risk stratification are warranted. 
 Magnetic resonance imaging (MRI) is widely used for preoperative pelvic assessment 
of endometrial cancer (9-11). Additionally, most patients undergo an abdominal and thoracic 
computed tomography (CT) scan as part of the routine preoperative diagnostic workup. Some 
institutions also include 18-fluoro-deoxy-glucose (FDG)-positron-emission tomography (PET) 
in preoperative assessments, due to its high diagnostic value in detecting lymph node metastases 
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(12). Texture analysis, a method for quantification of heterogeneity in images which is 
applicable to both MRI, PET and CT, is increasingly employed in clinical research. As a post-
processing tool, image texture analysis does not increase scan time or patient-related side effects 
e.g. radiation dose, and thus represents an intriguing adjunct to conventional imaging. Image 
texture features have been proposed as imaging markers yielding more accurate diagnosis, 
improved preoperative risk stratification and better assessment of treatment response in several 
cancer types, e.g. in the brain (13), lung (14), breast (15) and prostate (16). Recent publications 
also report texture analysis of MRI (17, 18) and PET (19) as promising tools for preoperative 
risk stratification in endometrial cancer. No prior study has evaluated the possible value of CT 
texture analysis (CTTA) in endometrial cancer. 
This study aimed to explore whether the staging parameters pathological deep (≥50%) 
myometrial invasion (pDMI), cervical stroma invasion (pCSI) and lymph node metastases 
(pLNM), high-risk histological subtype and clinical outcome in endometrial cancer patients, 
are reflected in CTTA features. 
 
Materials and Methods 
 
Study setting 
This study was conducted with written informed consent from all patients and approval 
by the regional ethics committee. From April 2009 to November 2013 preoperative pelvic 
contrast-enhanced CT (ceCT) was performed in 155 women with endometrial cancer 
histologically verified at subsequent surgical staging. The CT scans were performed at different 
local hospitals. All patients were treated at the same university hospital, which is a European 
Society of Gynaecological Oncology accredited center. The last follow-up was in January 2017 
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and median follow-up time for the group of patients without recurrence or progression was 50 
months (range 0-85). 
 
Histological diagnosis 
Mean interval between the CT examination and surgical staging was 7 (range 1-102) 
days. The preoperative biopsy was graded as either low-risk (endometrioid grade 1-2) or high-
risk (endometrioid grade 3 or non-endometrioid) endometrial cancer. From preoperative 
endocervical curettage, an assessment of cervical tumour involvement was also performed. 
All patients were surgicopathologically staged according to the 2009 FIGO staging 
system (7). Hysterectomy specimens were sectioned along the longitudinal plane of the uterus, 
and myometrial invasion and cervical stroma invasion were estimated grossly and confirmed 
microscopically according to standard criteria (20). In this paper we use the notation pDMI, 
pCSI and pLNM to indicate surgicopathological staging results, as opposed to imaging findings 
(e.g. iDMI indicating presence of ≥50% myometrial invasion on MRI). 
 
Imaging protocol 
CT was performed on different scanners at different local hospitals in Western Norway. 
Imaging data have been retrospectively collected, and thus, were not acquired using a 
standardised protocol. However, all patients underwent ceCT in a routine clinical setting as part 
of the diagnostic workup of endometrial cancer. Only portovenous contrast phase images 
acquired with diagnostic CT radiation dose and reconstructed with a soft tissue algorithm were 
considered eligible for the study. All patients had CT images reconstructed in axial, coronal and 
sagittal plane, aligned to the body axis (not to the long axis of the uterus). Section thickness 





A previously published study on MRI texture analysis (18) included 180 endometrial 
cancer patients. This MRI study was prospective with a standardised scan protcol based on 
guidelines from the European Society of Urogenital Imaging (ESUR) (10). In 169 of these 
180 patients, a pelvic ceCT was available. One radiologist (SYH) with 6 years of experience 
with pelvic CT and MR imaging, blinded for clinical and histological data, assessed the 
eligibility of the images for CTTA. Of the 169 patients with a ceCT, 14 were excluded due to 
poorly defined tumours, considered ineligible for reliable tumour texture analysis. Thus, 155 
patients were included for CTTA. Aiming at selecting the image series best approximating a 
true cross-sectional tumour plane, axial or coronal (depending on the degree of ante-
/retroflection of the uterus) ceCT images were exported to the commercially available 
research software TexRAD (TexRAD Ltd, part of Feedback Plc). Then, the image slice 
displaying the largest cross-sectional tumour area was selected for texture analysis. In cases 
with several candidate slices, the radiologist subjectively selected one single slice based on 
the criteria large tumour area, good image quality and high tumour-background contrast. 
Median number of pixels in regions of interest (ROIs) was 466 (range 53-7541). 
 
Texture analysis 
In TexRAD the radiologist (SYH) manually drew ROIs on the CT slice displaying the 
largest cross-sectional tumour area, aiming at including all viable tumour tissue (Figure 1). To 
optimise tumour segmentation, MR images (T2-weighted, diffusion weighted and contrast 
enhanced T1-weighted images) were available when drawing ROIs on CT images (Suppl. 
Figure 1AB). The ROIs were processed using a filtration-histogram technique (21), in which 
image elements, i.e. groups of pixels with similar density, of different sizes were enhanced 
corresponding to spatial scale filter (SSF) from 2-6 mm, i.e. fine (2 mm), medium (3-5 mm) 
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and coarse texture (6 mm) (Figure 1). Quantification of texture in tumour ROIs comprised 
mean density, standard deviation (SD), entropy, mean of positive pixels (MPP), skewness and 
kurtosis. The total number of texture variables included in the statistical analyses was 36 
(mean/SD/entropy/skewness/MPP/kurtosis at SSF 0/2/3/4/5/6). A condensed notation is used 
in this manuscript, e.g. Entropy6, indicating tumour ROI entropy in ceCT image at SSF 6. 
The additional time consume for image slice selection and export, tumour delineation and 
texture analysis was approximately 10-15 minutes per patient. 
 
Statistical analysis 
The majority of texture variables did not have normal distribution, thus non-parametric 
tests were chosen. Mann-Whitney U Test was used to evaluate associations between tumour 
texture variables and the pathological outcome variables pDMI, pCSI, pLNM and high-risk 
histological subtype (defined as endometrioid grade 3 or non-endometrioid). The texture 
variables were subsequently ranked according to lowest p-value, and the highest ranked 
variables were selected for receiver operator characteristic (ROC)-curve analyses and 
univariable and multivariable logistic regression. The selected texture variables were analysed 
both as continuous and categorical variables. To generate the categorical variables, cutoff 
values determined by the maximum Youden index (defined as the sum of sensitivity and 
specificity) were used. In the multivariable analyses, we adjusted for age, preoperative biopsy 
risk status and conventional MRI reading results including MRI-measured tumour volume. 
Results from conventional MRI (assessment of tumour size, myometrial (iDMI) and cervical 
invasion (iCSI) and presence of lymph node metastases (iLNM)) were recorded as consensus 
opinion from three radiologists (median values for continuous variables and majority for 
categorical variables) having independently read the same MR images in a prior study (22). 
Spearman’s bivariate correlation test was used to explore correlations. 
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Survival analysis was performed with all texture variables separately in univariable 
Cox regression analysis for predicting recurrence- and progression-free survival (RPFS), i.e. 
time to recurrence (for patients considered to be cured by primary treatment) or progression 
(for patients known to have residual disease after primary treatment). Ranked according to 
lowest p-value, the best predictor was selected to be included in a multivariable analysis also 
including MRI-measured tumour volume, preoperative biopsy risk status and age. For the top 
ranked texture variable, difference in RPFS was assessed by the Mantel-Cox test and Kaplan-
Meier plot, in which consecutive groups (quartiles) with similar survival were merged. 
For the testing of the 36 texture variables, an adjustment for inter-variable correlations 
(Suppl. Table 1) was done and the significance level was set to 0.0025. With this significance 
level for the 36 individual tests, a random allocation (without replacement) of the 36-variate 
texture variables to outcome group had approximately 5% chance of at least one significant 
result. 
In the multivariable analyses a traditional significance level of 0.05 was used. 





Median patient age at primary treatment in the study cohort (n=155) was 68 years (range 
41-89). Primary surgical treatment included bilateral salpingo-oophorectomy and hysterectomy 
for 98% (152/155), tumour reduction surgery for 1/155 and curettage only for 2/155. 
Lymphadenectomy was performed in 85% (131/155), pelvic only in 105 patients, pelvic and 
para-aortic in 26 patients. In patients who underwent lymphadenectomy, the mean number of 
resected nodes was 17 (range 1-54). FIGO stage was IA in 47% (73/155), IB in 27% (42/155), 
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II in 10% (16/155), IIIB in 2% (3/155), IIIC1 in 7% (11/155), IIIC2 in 4% (6/155), IVA in 1% 
(1/155) and IVB in 2% (3/155). Histological subtype was endometrioid in 78% (121/155), clear 
cell in 3% (5/155), serous in 10% (16/155), carcinosarcoma in 6% (9/155) and 
undifferentiated/others in 3% (4/155). Among endometrioid tumours, histological 
differentiation was grade 1 in 43% (52/121), grade 2 in 32% (39/121), grade 3 in 23% (28/121) 
and ungraded in 2% (2/121). Adjuvant therapy was given to 41% (63/155); comprising 
chemotherapy in 54 patients, radiotherapy (external or internal) in 8 patients and hormonal 
treatment in 1 patient. 
 
Prediction of deep myometrial invasion (pDMI) 
Of the 36 texture features assessed, 15 significantly (p<0.0025) predicted pDMI in 
univariable analysis with entropy at filter level 6 (Entropy6) yielding highest significance 
(Suppl. Table 2 and 3). The majority of these features comprised entropy and kurtosis at 
various filter levels, yielding the top 6 significant predictors (Suppl. Table 3). High values for 
Entropy6 independently predicted pDMI with an odds ratio (OR) of 3.7 (95% confidence 
interval 1.4-9.7, p=0.008) when adjusting for high-risk status based on preoperative biopsy 
(endometrioid grade 3 or non-endometrioid), conventional MRI reading suggesting iDMI, 
MRI-measured tumour volume and age (Table 1). The receiver operator characteristic (ROC)-
analysis yielded an area under the Entropy6 ROC-curve (AU-ROC) of 0.71 (p<0.001) (Figure 
2a) for prediction of pDMI. 
 
Prediction of cervical stroma invasion (pCSI) 
For prediction of pCSI in univariable analysis, none of the 36 texture features reached 
the significance level of 0.0025. The top ranked predictor of pCSI, Entropy6 (also the best 
predictor of pDMI), was, however, borderline significant in univariable analysis (p=0.006), 
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whereas in the multivariable analysis (significance level 0.05) high values of Entropy6 
independently predicted pCSI with an odds ratio of 3.9 (1.2-12.4, p=0.02) when adjusting for 
preoperative endocervical curettage indicating cervical tumour invasion, conventional MRI 
reading suggesting iCSI, MRI-measured tumour volume and age (Table 1). The 
corresponding AU-ROC for Entropy6 was 0.67 (p=0.005) (Figure 2b) for prediction of pCSI. 
 
Prediction of lymph node metastases (pLNM) 
None of the 36 texture features were significant predictors of pLNM neither in 
univariable analysis nor in multivariable analysis. The top ranked feature, Kurtosis5, yielded 
an AU-ROC of 0.69 (p=0.01) (Figure 2c) for prediction of pLNM. 
 
Prediction of high-risk histological subtype 
Two of the tested 36 texture features, MPP5 and Entropy4, were significant 
(p<0.0025) predictors of high-risk histological subtype (endometrioid grade 3 and non-
endometrioid tumours) in univariable analysis (Suppl. Table 2 and 3). In the multivariable 
analysis, high values of the top ranked predictor, MPP5, only tended to predict high-risk 
histological subtype (OR 1.01 (1.00-1.03, p=0.10)) when adjusting for high-risk status based 
on preoperative biopsy, MRI-measured tumour volume and age (Table 1). However, when a 
cutoff based on the highest Youden index was applied, MPP5>24.2 independently predicted 
high-risk histological subtype in the same multivariable model (OR 3.7 (1.3-10.1, p=0.01)). 
The corresponding AU-ROC for MPP5 was 0.65 (p=0.002) (Figure 2d) for prediction of high-





Three out of 36 texture features significantly (p<0.0025) predicted recurrence- and 
progression-free survival (RPFS) in univariable Cox regression analysis. These comprised 
kurtosis at filter level 5, 4 and 3, respectively (Suppl. Table 3). High values of the top ranked 
prognostic texture feature, Kurtosis5 (also the best predictor of pLNM), predicted reduced 
survival with a hazard ratio of 1.2 (1.1-1.2, p<0.001) in univariable analysis (Table 2). When 
adjusted for high-risk status based on preoperative biopsy, MRI-measured tumour volume and 
age, however, the significance was only borderline (p=0.06). 
Significantly reduced recurrence- and progression-free survival was observed for 
patients with Kurtosis5 value being above the 75-percentile compared with patients having 
Kurtosis5 value below the 75-percentile (Figure 3, p<0.001). The proportion of patients given 
adjuvant treatment was higher in the poor outcome group: 59% (23/39) received adjuvant 
treatment among patients with Kurtosis5 above the 75-percentile, whereas only 34% (40/116) 
received adjuvant treatment among patients with Kurtosis5 below the 75-percentile. 
 
Discussion 
In this study we have demonstrated that texture features derived from preoperative CT 
are associated with high-risk disease and reduced survival in endometrial cancer. Our findings 
suggest that tumour texture analysis also employed on CT scans may yield clinically relevant 
imaging markers that may aid in the preoperative staging and risk assessment. 
 Surgical staging and subsequent histological assessment have traditionally been the 
primary basis for treatment and prognostication in endometrial cancer, thereby allowing only 
limited risk stratification prior to surgery. In this study we link novel CT features that may be 
derived from routinely employed preoperative scanning, to established risk factors in 
endometrial cancer, and identify tumour texture features that non-invasively and accurately 
may predict high-risk disease preoperatively. Interestingly, in multivariable analyses when 
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adjusting for other relevant routinely obtained preoperative biomarkers, the texture feature 
Entropy6 remains a significant and independent predictor of both pDMI and pCSI. 
Furthermore, in the multivariable survival analysis, the texture feature Kurtosis5 tends to 
predict recurrence- and progression-free survival. 
Among the CT derived texture features in this study we found entropy, kurtosis and to 
some extent MPP to be the most promising markers in endometrial cancer. These findings are 
in concordance with a prior endometrial cancer study applying texture analysis on MRI with a 
similar approach (18). Entropy is a measure of random irregularity and kurtosis is related to 
the peakedness of the pixel distribution curve in ROIs. In general, high entropy and high 
kurtosis in CT images reflect increased histological heterogeneity (23), which in turn is often 
related to irregular tissue architecture induced by tumour-induced angiogenesis, hypoxia and 
necrosis (24). Although texture features at different filter levels in our study are highly 
correlated (Suppl. Table 1), there is a tendency towards medium to coarse filtration being 
more frequently represented among high ranked predictors of high-risk disease (Suppl. Table 
3). This observation may support that the filtering-algorithm in TexRAD in fact enhances the 
biologically relevant information in medical images, as hypothesised (25). 
Inherently, CT has a lower soft tissue contrast than MRI, and in endometrial cancer 
CT has traditionally played a limited role in the assessment of local tumour extent. Although 
not fully comparable, a previous study with overlapping patient cohort employing MR texture 
analysis (MRTA) (18), identified features yielding slightly higher predictive and prognostic 
value than the most significant CTTA features in the present study. The MRTA markers 
yielded higher AUC than CTTA for prediction of pDMI (ADC_Entropy6 0.81 versus 
CT_Entropy6 0.71), pLNM (T1c_Entropy6 0.73 versus CT_ Kurtosis5 0.69) and high-risk 
histological subtype (T1c_MPP4 0.66 versus CT_MPP5 0.65) and higher hazard ratio (1.5 for 
T1c_Kurtosis2 versus 1.1 for CT_Kurtosis5) for predicting recurrence- and progression-free 
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survival. Nevertheless, the current study demonstrates that in spite of the lower soft tissue 
contrast, CT derived texture features may aid in the preoperative risk assessment as an adjunct 
to MRI. In fact, for prediction of pCSI, CTTA yielded slightly higher AUC than MRTA 
(CT_Entropy6 0.67 versus T2_MPP4 0.64), and if MRI is not available, the role of CTTA 
may potentially be even more important. In this context, however, it should be noted that our 
study allowed corresponding MR images to assist in tumour segmentation (to minimise ROI 
contamination) and as such, further studies are required to evaluate CTTA as a standalone 
prognosticator. Furthermore, our study does not propose a complete risk predicting model for 
endometrial cancer. However, given the previously published results on image texture 
analysis of MRI (17, 18) and PET (19), it seems plausible that a “texture signature”, including 
features from different imaging modalities, could improve preoperative risk stratification in 
endometrial cancer patients. 
The presence of lymph node metastases at surgical staging is an important risk 
classifier. In this study CTTA does not independently predict pLNM. A prior MRTA study 
also failed to identify independent predictors of pLNM among 87 texture features (18). 
Preoperative biomarkers for prediction of pLNM need to yield high diagnostic performance if 
these biomarkers are to guide tailored surgical treatment strategies offering less invasive 
surgery in low-risk patients. It is worth noting that aggressive disease does not always present 
with macroscopic lymph node metastases at the time of diagnosis or staging. Thus, if imaging 
can provide accurate prediction of pDMI, pCSI and histological type and grade, this would 
also be an important contribution to preoperative risk stratification. Anyhow, since no single 
promising texture marker for prediction of pLNM is currently identified, a future risk 
prediction model would probably benefit from a more multimodal and integrative approach, 
tentatively including elements from biopsy specimen (histological and molecular markers), 
blood sample, radiology and clinical information. 
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Our study has some limitations. First, the CT images were acquired using a non-
standardised imaging protocol, and hence the heterogeneous dataset represents a potential 
bias. E.g. differences in the quantities and types of contrast media administered may have had 
an impact on the derived image texture features. This, however, primarily increases the risk of 
type II errors, and our findings of independent predictors of high-risk disease could thus be 
regarded even more robust, as they are based on imaging data from routine clinical practice. 
Second, intra- and interobserver variability for the texture measurements has not been 
assessed in this study, in which manual segmentation was performed. Although not directly 
comparable, prior CTTA studies using the same software in other cancer types have shown 
good to excellent interobserver agreement (26, 27).  
Third, the two-dimensional, filtration-histogram based approach in TexRAD does not 
cover all aspects of texture analysis, and a three-dimensional approach analysing the entire 
tumour volume could potentially have yielded more relevant information on tumour texture. 
The literature is, however, equivocal regarding the superiority of whole tumour volume 
texture analysis over largest cross-sectional tumour area texture analysis. Studies on CT 
texture analysis in colorectal cancer yielded similar results for 2D and 3D segmentation of 
liver metastases (28), whereas for primary tumours the 3D segmentation yielded slightly 
better prognostic markers than that based on 2D segmentation (29). Since 2D segmentation is 
less time consuming, it is still widely used; however, with the introduction of more automated 
tumour segmentation tools, whole volume texture analyses may be easier to conduct in the 
future. 
 In conclusion, preoperative tumour texture analysis from CT yields imaging markers 
that independently predict high-risk disease and tend to predict reduced survival in 
endometrial cancer patients. This approach using radiomics to yield prognostic markers may 
enhance the role of standard diagnostic imaging methods and potentially contribute to 
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preoperative risk stratification in endometrial cancer. However, the value of image texture 
analysis in endometrial cancer needs to be further evaluated and validated across observers, 
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Univariable and multivariable logistic regression for prediction of deep myometrial invasion, cervical stroma invasion, 
lymph node metastases and high-risk histological subtype at surgical staging. The top ranked CT derived texture feature is 
included in each category. 
 
 




     
Dependent variable  




Unadjusted OR (95% CI) p  Adjusted* OR (95% CI) p 




ceCT_Entropy6 6.7 (2.8-16.0) <0.001  3.7 (1.4-9.7) 0.008 
MRI tumour volume 1.04 (1.02-1.07) <0.001  1.03 (1.00-1.05) 0.02 
MRI reading iDMI+ 5.0 (2.5-10.0) <0.001  2.3 (1.0-5.1) 0.04 
High-risk biopsy a 0.9 (0.5-1.9) 0.86  0.6 (0.2-1.4) 0.20 
Age 1.04 (1.00-1.07) 0.04  1.03 (0.99-1.07) 0.15 
 Predictor with cutoff b      
(n=71/153) ceCT_Entropy6 ≥4.84 3.9 (2.0-7.7) <0.001  2.4 (1.1-5.2) 0.02 




ceCT_Entropy6 4.4 (1.5-12.8) 0.006  3.9 (1.2-12.4) 0.02 
MRI tumour volume 1.01 (1.00-1.01) 0.15  1.00 (0.99-1.01) 0.73 
MRI reading iCSI+ 4.9 (1.7-13.9) 0.003  3.8 (1.1-13.4) 0.03 
Biopsy Cervix+ 2.0 (1.0-3.7) 0.04  2.1 (1.0-4.2) 0.04 
Age 1.02 (0.98-1.07) 0.27  1.02 (0.98-1.07) 0.37 
 Predictor with cutoff b      
(n=68/153) ceCT_Entropy6 ≥4.85 4.6 (1.8-11.8) 0.001  4.5 (1.6-12.6) 0.004 




ceCT_Kurtosis5 1.3 (1.1-1.7) 0.01  1.1 (0.8-1.5) 0.75 
MRI tumour volume 1.02 (1.01-1.03) 0.005  1.02 (1.00-1.03) 0.06 
MRI reading iLNM+ 21.6 (5.3-87.9) <0.001  12.2 (2.5-59.0) 0.002 
High-risk biopsy a 3.4 (1.2-9.9) 0.03  1.8 (0.5-6.4) 0.38 
Age 1.02 (0.97-1.08) 0.41  1.00 (0.93-1.07) 0.90 
 Predictor with cutoff b      
(n=61/131) ceCT_Kurtosis5 >0.16 6.0 (1.6-22.4) 0.007  3.4 (0.8-14.0) 0.09 




ceCT_MPP5 1.01 (1.00-1.03) 0.02  1.01 (1.00-1.03) 0.10 
MRI tumour volume 1.02 (1.01-1.03) 0.004  1.02 (1.00-1.03) 0.05 
High-risk biopsy a 30.2 (10.6-85.5) <0.001  29.4 (10.0-86.4) <0.001 
Age 1.02 (0.99-1.06) 0.21  1.00 (0.96-1.05) 0.96 
 Predictor with cutoff b      
(n=96/153) ceCT_MPP5 >24.2 4.7 (2.2-10.2) <0.001  3.7 (1.3-10.1) 0.01 
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a High-risk-histological subtype is defined as endometrioid grade 3 or non-endometrioid subtype as opposed to low-risk 
histological subtype defined as endometrioid grade 1 and 2. 
b Cutoffs are determined by ROC curve analysis selecting the highest Youden index. Multivariable analyses are identical except 
texture variables are now categorical. 
* All covariates listed behind each dependent variable, grouped by vertical leaders, are included in each multivariable analysis. 
(When analysing texture variables with cutoff, the continuous variable is replaced by the corresponding categorical variable in the 
same analysis.) 
Significant p values (p<0.0025 in univariable analyses (after correction for number of test variables and inter-variable correlations) 
and p<0.05 in multivariable analyses) are given in bold. 
Texture features are annotated with number indicating spatial scale filter (SSF). 
ceCT, contrast-enhanced CT; CI, confidence interval; CT, computed tomography; iCSI, imaging-assessed cervical stroma invasion; 
iDMI, imaging-assessed deep myometrial invasion; iLNM, imaging-assessed lymph node metastases; MPP, mean of positive 
pixels; MRI, magnetic resonance imaging; OR, odds ratio; pCSI, pathology-assessed cervical stroma invasion; pDMI, pathology-








Univariable and multivariable Cox regression analysis for prediction of recurrence- and progression-free survival after 
treatment for endometrial cancer (n=155). 
 




     
Outcome Predictor Unadjusted HR (95% CI) p  Adjusted HR (95% CI) p 
       
RPFS 
ceCT_Kurtosis5 1.2 (1.1-1.2) <0.001  1.1 (1.0-1.2) 0.06 
MRI tumour volume 1.01 (1.00-1.01) <0.001  1.01 (1.00-1.01) 0.01 
High-risk biopsy a 3.6 (1.9-6.9) <0.001  2.6 (1.3-5.2) 0.01 
Age 1.03 (1.00-1.07) 0.06  1.02 (0.98-1.05) 0.33 
       
a Categorical variable. High-risk biopsy is defined as endometrioid grade 3 or non-endometrioid subtype as opposed to low-risk 
comprising endometrioid grade 1 and 2. 
Significant p values (p<0.0025 in univariable analyses (after correction for number of test variables and inter-variable correlations) 
and p<0.05 in multivariable analyses) are given in bold. 
The texture feature (ceCT_Kurtosis5) is annotated with a number indicating spatial scale filter (SSF=5). 
ceCT, contrast-enhanced CT; CI, confidence interval; CT, computed tomography; HR, hazard ratio; MRI, magnetic resonance 





Figure legends  
 
Figure 1  
Endometrial carcinoma manually segmented (blue line) on contrast-enhanced CT image in (a) 
an 81-year-old woman diagnosed with stage 1a cancer (endometrioid grade 1). Texture 
analysis showed low tumour entropy (Entropy6=4.49 corresponding to 25-percentile in study 
cohort). (b) An 88-year-old woman with stage 2 cancer (endometrioid grade 1) and high 
tumour entropy (Entropy6=5.54 corresponding to 95-percentile). Native image on top and 
fine, medium and coarse filtration of the tumour depicted below. 
 
Figure 2 
Receiver operator characteristics (ROC)-curves visualising the diagnostic performance of the 
top ranked texture features for predicting presence of the staging parameters deep myometrial 
invasion (pDMI) (a), cervical stroma invasion (pCSI) (b), lymph node metastases (pLNM) (c) 
and for high-risk histological subtype (d). P values refer to the test of equal areas under the 
diagonal and the ROC-curve. AUC, area under the ROC-curve. 
 
Figure 3 
Kaplan-Meier plot depicting significantly different patient survival for the top ranked tumour 
texture feature Kurtosis5. High tumour values for Kurtosis5 (above 75-percentile) were 
significantly associated with reduced recurrence- and progression free survival (p<0.001). P 





Suppl. Figure 1A 
Corresponding MR images (a-e) and tumour segmented CT image (f) in an 81-year-old woman 
diagnosed with stage 1a cancer (endometrioid grade 1) (same patient as in Figure 1a): Sagittal 
T2, depicting MRI axial oblique plane (red line) and CT coronal plane (blue line) (a), axial 
oblique T2 (b), axial oblique contrast-enhanced T1 (c), DWI b1000 (d), ADC-map (e) and 
contrast-enhanced CT image with tumour delineation (blue line) (f). The coronal CT plane was 
the best approximation of a true cross-sectional tumour plane in this patient – due to the uterus 
being anteverted. 
 
Suppl. Figure 1B 
Corresponding MR images (a-e) and tumour segmented CT image (f) in an 88-year-old woman 
with stage 2 cancer (endometrioid grade 1) (same patient as in Figure 1b): Sagittal T2, depicting 
MRI axial oblique plane (red line) and CT axial plane (blue line) (a), axial oblique T2 (b), axial 
oblique contrast-enhanced T1 (c), DWI b1000 (d), ADC-map (e) and contrast-enhanced CT 
image with tumour delineation (blue line) (f). Notice that the axial CT plane was the best 
approximation of a true cross-sectional tumour plane, being almost identical to the slightly 













Suppl. Table 1 
Spearman correlation coefficients (rs) for CT derived texture features (at different filter levels (SSF 0-6)) in tumour ROIs 
of 155 endometrial cancer patients. 







SSF  0 2 3 4 5 6 
 
0 2 3 4 5 6 
 
0 2 3 4 5 6 
 
0        
 
        
 
      
 
2 rs 0.14 
 





























































































































   
        







SSF  0 2 3 4 5 6 
 
0 2 3 4 5 6 
 
0 2 3 4 5 6 
 
0        
 
        
 
           
 
2 rs 0.11 
 




































































































































** Correlation is significant at the 0.0025 level (2-tailed). 
* Correlation is significant at the 0.05 level (2-tailed). 





Suppl. Table 2 
Top ranked CT derived texture features in relation to clinical and histological characteristics of 155 endometrial cancer patients. 
 
 






      
Variable n Median (95% CI) p*  Median (95% CI) p*  Median (95% CI) p* 
Myometrial invasion    <0.001   <0.001   <0.001 
<50% 83 4.7 (4.5-4.8)   24 (19-28)   -0.3 (-0.4-0.0)  
≥50% (pDMI) 70 5.0 (4.8-5.1)   36 (28-44)   0.3 (0.1-0.9)  
Cervical stroma invasion    0.005   0.03   0.71 
No 126 4.8 (4.7-4.8)   26 (22-31)   0.0 (-0.2-0.2)  
Yes (pCSI) 27 5.1 (4.9-5.2)   34 (27-45)   0.2 (-0.6-1.4)  
Lymph node metastases    0.10   0.56   0.01 
No 115 4.8 (4.7-4.9)   28 (25-34)   0.0 (-0.3-0.2)  
Yes (pLNM) 16 5.1 (4.7-5.3)   32 (18-57)   0.8 (0.2-2.1)  
Histological type/grade   0.007   0.002   0.02 
E1+2 91 4.7 (4.6-4.8)   24 (20-31)   0.0 (-0.3-0.2)  
E3+NE 62 4.9 (4.8-5.1)   35 (29-44)   0.3 (-0.2-1.0)  
Age, years   0.30   0.008   0.16 
<68 77 4.8 (4.6-4.9)   25 (20-31)   -0.1 (-0.3-0.2)  
≥68 (median and above) 78 4.8 (4.7-5.0)   35 (27-44)   0.3 (-0.2-0.8)  
BMI, kg/m2   0.05   0.14   0.28 
<25 45 5.0 (4.7-5.2)   33 (24-45)   0.3 (-0.1-0.8)  
≥25 (overweight) 107 4.8 (4.7-4.9)   28 (24-31)   0.0 (-0.3-0.2)  
* Mann-Whitney U Test. 
a Highest ranked CT derived texture feature for prediction of myometrial invasion (pDMI) and cervical stroma invasion (pCSI). 
b Highest ranked CT derived texture feature for prediction of histological type/grade. 
c Highest ranked CT derived texture feature for prediction of lymph node metastases (pLNM) and recurrence- and progression-free 
survival.  
Texture features are annotated with number indicating spatial scale filter (SSF). 
Significant p values after correction for number of test variables and inter-variable correlations (<0.0025) are given in bold. 
BMI, body mass index; CI, confidence interval; CT, computed tomography; E1-3, endometrioid grade 1-3; MPP, mean of positive pixels; 
NE, non-endometrioid; pCSI, pathology-assessed cervical stroma invasion; pDMI, pathology-assessed deep myometrial invasion; pLNM, 




Suppl. Table 3 
Top ranked CT derived texture features for predicting FIGO staging parameters, histological tumour characteristics and survival in 155 endometrial cancer patients. 
 
  
Deep myometrial invasion 
(pDMI) 
  
Cervical stroma invasion 
(pCSI) 
  






Reduced recurrence- and 
progression-free survival 
         
Rank Texture feature p*  Texture feature p*  Texture feature p*  Texture feature p*  Texture feature p+ 
1 Entropy6 8.74×10-6  Entropy6 0.0053  Kurtosis5 0.0121  MPP5 0.0016  Kurtosis5 1.44×10-6 
2 Kurtosis3 9.52×10-6  Entropy5 0.0075  Kurtosis4 0.0123  Entropy4 0.0022  Kurtosis4 2.05×10-5 
3 Kurtosis4 1.97×10-5  Entropy4 0.0153  Kurtosis2 0.0149  Entropy5 0.0029  Kurtosis3 1.80×10-5 
4 Entropy5 6.97×10-5  MPP4 0.0193  Kurtosis6 0.0192  Entropy3 0.0037  Kurtosis6 0.0067 
5 Entropy2 2.96×10-4  Skewness3 0.0344  Kurtosis3 0.0320  Entropy6 0.0068  Skewness3 0.0114 
6 Kurtosis5 2.99×10-4  MPP5 0.0346  Entropy2 0.0365  MPP6 0.0068  Entropy5 0.0114 
7 MPP6 3.54×10-4  SD5 0.0405  MPP0§ 0.0415  MPP4 0.0109  Entropy6 0.0126 
8 Mean5 4.27×10-4  SD4 0.0417  Mean0§ 0.0422  Skewness2 0.0117  Skewness4 0.0155 
9 Mean6 4.33×10-4  SD6 0.0424  Entropy5 0.0730  SD6 0.0128  Entropy4 0.0243 
10 Kurtosis2 4.48×10-4  MPP3 0.0476  Entropy0 0.0800  Skewness3 0.0185  Kurtosis2 0.0250 
 
* Mann-Whitney U Test. 
+ Univariable Cox regression analysis. 
§ Low values of MPP0 and Mean0 predicted lymph node metastases. For all other texture features listed, high values predicted high-risk disease. 
Significant p values after correction for number of test variables and inter-variable correlations (<0.0025) are given in bold. 
Texture features are annotated with number indicating spatial scale filter (SSF). 
ceCT, contrast-enhanced CT; CT, computed tomography; E3, endometrioid grade 3; FIGO, the International Federation of Gynecology and Obstetrics; MPP, mean of positive pixels; NE, 
non-endometrioid; pCSI, pathology-assessed cervical stroma invasion; pDMI, pathology-assessed deep myometrial invasion; pLNM, pathology-assessed lymph node metastases; SD, 
standard deviation. 
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